Article

Integrating Multimodal Data for Precise Subtyping and Prognostication in Pulmonary Mucinous Adenocarcinoma

2025-10-17

Abstract excerpt

<title>Abstract</title> <p>Background Pulmonary mucinous adenocarcinoma (PMA) represents a rare lung adenocarcinoma subtype, characterized by a lacks of comprehensive pathological classification and prognostic factors. In this study, we introduce a multimodal machine learning framework aimed at improving the accuracy of PMA subtyping and predicting the prognosis of PMA patients. Materials and methods This retrosp...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: f3f0ca15-4061-5306-a391-4d200505b344
DOI: 10.21203/rs.3.rs-7827699/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Integrating Multimodal Data for Precise Subtyping and Prognostication in Pulmonary Mucinous AdenocarcinomaDOI 10.21203/rs.3.rs-7827699/v1Read

Analysis of the clinicopathological characteristics, genetic phenotypes, and prognostic of pure mucinous adenocarcinoma.Semantic proximity Read

Molecular characteristics, clonal relatedness and surgical outcomes of pulmonary mixed invasive mucinous and non-mucinous adenocarcinoma: a retrospective cohort study.Semantic proximity Read

Multi-omics characterization and machine learning of lung adenocarcinoma molecular subtypes to guide precise chemotherapy and immunotherapy.Semantic proximity Read

Integrated multi-omics analysis and machine learning to refine molecular subtypes, prognosis, and immunotherapy in lung adenocarcinomaSemantic proximity Read

The utility of the proposed IASLC/ATS/ERS lung adenocarcinoma subtypes for disease prognosis and correlation of driver gene alterations.Semantic proximity Read

The new IASLC-ATS-ERS lung adenocarcinoma classification: what the surgeon should know.Semantic proximity Read

Simplified Molecular Classification of Lung Adenocarcinomas Based on EGFR, KRAS, and TP53 MutationsSemantic proximity Read

Lung adenocarcinomas with mucinous histology: clinical, genomic, and immune microenvironment characterization and outcomes to immunotherapy-based treatments and KRASG12C inhibitors.Semantic proximity Read

Genomic and Immunological Features of Micropapillary Pattern in Lung AdenocarcinomaSemantic proximity Read

Development of a Tumour Metabolism and Immune Microenvironment-Based Prognostic Model for Prognosis and Anti-Cancer Drug Response in Lung AdenocarcinomaSemantic proximity Read

Development of a Novel Prognostic Score Combining Clinicopathologic Variables, Gene Expression and Mutationprofiles for Lung AdenocarcinomaSemantic proximity Read

Development of a novel prognostic score combining clinicopathologic variables, gene expression, and mutation profiles for lung adenocarcinoma.Semantic proximity Read